Sorcero, a Washington, DC- and Cambridge, MA-based medical and technical Language Intelligence (LI) company, raised $10M in Series A funding.
The round, which brought total funding to $15.7m, was led by City Rock Ventures Partners and Harmonix Fund with participation from Rackhouse, Mighty Capital and Leawood VC, Castor Ventures and Worldquant Ventures.
The company intends to use the funds to serve more customers and expand the domain expertise of the team.
Led by Dipanwita Das, CEO, and Walter Bender, CTO, Sorcero provides a medical and technical Language Intelligence (LI) platform for life sciences and STEM enterprises. The delivers an increase in analytical capability and extracts complex insights to augment critical decision-making for some of the world’s largest and most innovative pharmaceutical, diagnostic and biotech organizations.